Theophylline, Anhydrous 400 mg / 1 Tablet 100 Tablet, Extended Release
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 42858-0701-01 |
|---|---|
| Product NDC | 42858-0701 |
| Generic Drug Name | Theophylline, Anhydrous |
| Brand Name | Theophylline, Anhydrous |
| Manufacturer | Rhodes Pharmaceuticals L.P. |
| Strength | 400 mg / 1 |
| Dosage Form | Tablet |
| Drug Type | Oral |
| Package Quantity | 100 Tablet, Extended Release |
| Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42858-701-01) |
| Active Ingredients | Theophylline Anhydrous |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Theophylline, Anhydrous 400 mg / 1 Tablet is tracked under NDC 42858-0701-01 and rolls up into product family 42858-0701. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 100 Tablet, Extended Release.
- Manufacturer: Rhodes Pharmaceuticals L.P..
- Dosage form: Tablet.
- Family size: 1 indexed presentation.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Potential alternatives with matching presentation
Open the comparison hub or review package-level listings from 4 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.
View Potential Alternative HubTheophylline Anhydrous, (Anhydrous) 400 mg / 1 Tablet extended release 100 Tablet, Extended Release Bottle4 package-level listings in the comparison hub.Sample package-level pages in this comparison set
Drug Shortage Information
Public evidence points to a current theophylline ER supply issue, with FDA shortage context and secondary provider-facing shortage summaries tying the exact Rhodes 42858-0701-01 product to the broader shortage history.
Drug Shortage Index family
View Theophylline anhydrous in the Drug Shortage IndexCompare related NDC-level product references and family-level shortage context for Theophylline anhydrous.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Theophylline, Anhydrous 400 mg / 1 Tablet 100 Tablet, Extended Release, NDC 42858-0701-01, is a Rhodes Pharmaceuticals L.P. 400 mg / 1 tablet presentation packaged as 100 Tablet, Extended Release. Current public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 42858-0701-01
- Digits-only NDC 11: 42858070101
- Possible 10-digit display formats: 42858-701-01 (4285870101), 42858-0701-1 (4285807011)
Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.
Helpful product links
- Search by brand name: Theophylline, Anhydrous
- NDC 11: 42858-0701-01
- Product family NDC: 42858-0701
- VA classification code: RE104
- VA classification code description: BRONCHODILATORS,XANTHINE-DERIVATIVE
- CMOP ID: T0681
- VUID: 4027422